Survival risk prediction nomogram for patients with resectable esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy followed by surgery: a retrospective study
NICT offers significant survival benefits for patients with resectable ESCC. The study identified age, neoadjuvant treatment cycles, cT, cN, and pN as independent risk factors impacting survival. The predictive model developed in this study can aid in selecting suitable postoperative adjuvant therapies, potentially enhancing treatment outcomes.
Authors
- Guibin Qiao (ORCID: https://orcid.org/0000-0001-9200-9317)
- Xin Xia (ORCID: https://orcid.org/0000-0001-7836-2317)
- Junhan Wu (ORCID: https://orcid.org/0000-0002-3726-5948)
- Yong Tang (ORCID: https://orcid.org/0000-0001-9478-5205)
- Zhe He (ORCID: https://orcid.org/0000-0002-8525-3650)
- Rixin Chen (ORCID: https://orcid.org/0000-0002-6729-4299)
- Qihang Zhu (ORCID: https://orcid.org/0000-0002-5776-5077)
Institutions
- ShenZhen People’s Hospital (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Zhujiang Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jtd-2025-1027
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00